# A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

> **NCT01808157** · PHASE2 · COMPLETED · sponsor: **Creabilis SA** · enrollment: 188 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** CT327 ointment
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01808157
- **Lead sponsor:** Creabilis SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808157, "A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01808157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*